ACL vs CGS

ASX Healthcare sector comparison — updated 3 Sep 2026 — Healthcare sector

ACL

AUCLINICAL FPO [ACL]

52MEDIUM

CGS

COGSTATE FPO [CGS]

57MEDIUM

Score Breakdown

ACL CGS
Technical
49
61
Catalyst
53
55
Sentiment
50
50
Fundamental
85
99
Momentum
58
64
Risk Gate
43
45

Key Metrics

ACL Metric CGS
$505.5MMarket Cap$523.4M
1.1MAvg Volume (20d)699K
+5.0%Short Interest+0.0%
$3.03052-Week High$3.230
$1.83352-Week Low$1.690
+0.0%Daily Change-0.3%
$2.710Reference Price$3.070
+14.9%ROE+22.5%
+3.2%Profit Margin+19.5%

Active Signals

ACL Signals

●MACD momentum is losing steam
●Drifting lower — down 3.2% over the last 5 days
●Beating the Small Ords index — relative strength of 1.16, so it's outpacing the pack
●Trading above the 200-day average — the long-term trend is on your side
●Cash positive / operating cashflow positive
●Low P/S ratio (0.7x)
●EPS estimates revised upward (+10pts)
●Earnings declining (-12% QoQ)

CGS Signals

●Beating the Small Ords index — relative strength of 1.21, so it's outpacing the pack
●Trading above the 200-day average — the long-term trend is on your side
●Cash positive / operating cashflow positive
●Moderate P/S ratio (8.6x)
●Moderate revenue growth (+16%)
●Piotroski F-Score strong (8/9, low-confidence approx)
●EPS estimates revised upward (+10pts)
●Near 52-week high (90% of range)

Ask Scout AI to compare ACL and CGS in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

AVE vs EPI →CUV vs HLS →NSB vs PHX →EPI vs PHX →AGN vs PHX →
ACL Full Analysis → CGS Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).